Kim ML, Sung KR, Kwon J et al. Neuroprotective effect of statins in a rat model of chronic ocular hypertension. Int J Mol Sci. 2021;22(22).12500
Article PubMed PubMed Central CAS Google Scholar
Shinozaki Y, Koizumi S. Potential roles of astrocytes and Müller cells in the pathogenesis of glaucoma. J Pharmacol Sci Japanese Pharmacol Soc. 2021;145:262–7.
Bourne RRA, Jonas JB, Friedman D et al. Global estimates on the number of people blind or visually impaired by glaucoma: a meta-analysis from 2000 to 2020. Eye [Internet]. 2024;38(11):2036–46. Available from: https://www.nature.com/articles/s41433-024-02995-5
Zhang N, Wang J, Chen B, et al. Prevalence of primary angle closure glaucoma in the last 20 years: a meta-analysis and systematic review. Front Med Volume. 2021;7:624179. Frontiers Media S.A.
Agarwal R, Agarwal P. Rodent models of glaucoma and their applicability for drug discovery. Expert opinion on drug discovery. Volume 12. Taylor and Francis Ltd; 2017. pp. 261–70.
Morrison JC, Johnson E, Cepurna WO. Rat models for glaucoma research. Prog Brain Res. 2008;173:285–301.
Haddaway NR, Page MJ, Pritchard CC, et al. PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis. Campbell Syst Rev. 2022;18(2):e1230.
PubMed PubMed Central Google Scholar
Ma LL, Wang YY, Yang ZH, et al. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: What are they and which is better? Military Medical Research. Volume 7. BioMed Central Ltd.; 2020. p. 7.
Hooijmans CR, Rovers MM, De Vries RBM, et al. SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14(1):43.
Article PubMed PubMed Central Google Scholar
Liang X, Li N, Rong Y, et al. Identification of proteomic changes for dexamethasone-induced ocular hypertension using a tandem mass tag (TMT) approach. Exp Eye Res. 2022;216:108914.
Article PubMed CAS Google Scholar
Sawaguchi K, Nakamura Y, Nakamura Y, et al. Myocilin gene expression in the trabecular meshwork of rats in a steroid-induced ocular hypertension model. Ophthalmic Res. 2005;37(5):235–42.
Article PubMed CAS Google Scholar
Miyara N, Shinzato M, Yamashiro Y, et al. Proteomic analysis of rat retina in a steroid-induced ocular hypertension model: Potential vulnerability to oxidative stress. Jpn J Ophthalmol. 2008;52(2):84–90.
Article PubMed CAS Google Scholar
Shinzato M, Yamashiro Y, Miyara N, et al. Proteomic analysis of the trabecular meshwork of rats in a steroid-induced ocular hypertension model: Downregulation of type I collagen C-propeptides. Ophthalmic Res. 2007;39(6):330–7.
Article PubMed CAS Google Scholar
Liu Y, Wang J, Jin X, et al. A novel rat model of ocular hypertension by a single intracameral injection of cross-linked hyaluronic acid hydrogel (Healaflow®). Basic Clin Pharmacol Toxicol. 2020;127(5):361–70.
Article PubMed CAS Google Scholar
Blanco R, Martinez-Navarrete G, Pérez-Rico C, et al. A chronic ocular-hypertensive rat model induced by injection of the sclerosant agent polidocanol in the aqueous humor outflow pathway. Int J Mol Sci. 2019;20(13):3209.
Article PubMed PubMed Central CAS Google Scholar
Noailles A, Kutsyr O, Mayordomo-Febrer A, et al. Sodium hyaluronate-induced ocular hypertension in rats damages the direction-selective circuit and inner/outer retinal plexiform layers. Invest Ophthalmol Vis Sci. 2022;63(5):2–2.
Article PubMed PubMed Central CAS Google Scholar
Emre E, Yüksel N, Duruksu G, et al. Neuroprotective effects of intravitreally transplanted adipose tissue and bone marrow-derived mesenchymal stem cells in an experimental ocular hypertension model. Cytotherapy. 2015;17(5):543–59.
Article PubMed CAS Google Scholar
Moreno MC, Aldana Marcos HJ, Croxatto JO, et al. A new experimental model of glaucoma in rats through intracameral injections of hyaluronic acid. Exp Eye Res. 2005;81(1):71–80.
Article PubMed CAS Google Scholar
Smedowski A, Pietrucha-Dutczak M, Kaarniranta K et al. A rat experimental model of glaucoma incorporating rapid-onset elevation of intraocular pressure. Sci Rep. 2014;4 :5910.
Li Q, Cheng Y, Zhang S et al. TRPV4-induced Müller cell gliosis and TNF-α elevation-mediated retinal ganglion cell apoptosis in glaucomatous rats via JAK2/STAT3/NF-κB pathway. J Neuroinflammation. 2021;18(1) :271.
Wang DD, Gao FJ, Zhang XJ, et al. Nobiletin protects retinal ganglion cells in models of ocular hypertension in vivo and hypoxia in vitro. Lab Invest. 2022;102(11):1225–35.
Article PubMed CAS Google Scholar
Huang W, Gao F, Hu F et al. Asiatic acid prevents retinal ganglion cell apoptosis in a rat model of glaucoma. Front Neurosci. 2018;12(JUL).
Zhang X, Li T, Zhang R, Li J, Wang K, Wu J. Downregulation of SARM1 protects retinal ganglion cell axonal and somal degeneration via JNK activation in a glaucomatous model of ocular hypertension. Investig Ophthalmol Vis Sci. 2024;65(13):7.
Yu S, Tanabe T, Yoshimura N. A rat model of glaucoma induced by episcleral vein ligation. Exp Eye Res. 2006;83(4):758–70.
Article PubMed CAS Google Scholar
Zhou X, Zhang T, Wu J. Brimonidine enhances inhibitory postsynaptic activity of OFF- and ON-type retinal ganglion cells in a Wistar rat chronic glaucoma model. Exp Eye Res. 2019;189:107833.
Article PubMed CAS Google Scholar
Zhou X, Cheng Y, Zhang R, et al. Alpha7 nicotinic acetylcholine receptor agonist promotes retinal ganglion cell function via modulating GABAergic presynaptic activity in a chronic glaucomatous model. Sci Rep. 2017;7(1):1734.
Article PubMed PubMed Central Google Scholar
Sun X, Cheng F, Meng B, et al. Pregnenolone sulfate decreases intraocular pressure and changes expression of sigma receptor in a model of chronic ocular hypertension. Mol Biol Rep. 2012;39(6):6607–14.
Article PubMed CAS Google Scholar
Yu S, Tanabe T, Dezawa M, et al. Effects of bone marrow stromal cell injection in an experimental glaucoma model. Biochem Biophys Res Commun. 2006;344(4):1071–9.
Article PubMed CAS Google Scholar
Su W, Li Z, Jia Y et al. Rapamycin is neuroprotective in a rat chronic hypertensive glaucoma model. PLoS ONE. 2014;9(6):e99719.
Gui D, Li Y, Chen X, et al. HIF1 signaling pathway involving iNOS, COX2 and caspase9 mediates the neuroprotection provided by erythropoietin in the retina of chronic ocular hypertension rats. Mol Med Rep. 2015;11(2):1490–6.
Article PubMed CAS Google Scholar
Woldemussie E, Ruiz G, Wijono M, et al. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension. Investig Ophthalmol Vis Sci. 2001;42(12):2849–55.
Soto I, Pease ME, Son JL, et al. Retinal ganglion cell loss in a rat ocular hypertension model is sectorial and involves early optic nerve axon loss. Invest Ophthalmol Vis Sci. 2011;52(1):434–41.
Article PubMed PubMed Central CAS Google Scholar
Yang F, Wang D, Wu L, et al. Protective effects of triptolide on retinal ganglion cells in a rat model of chronic glaucoma. Drug Des Devel Ther. 2015;9:6095–107.
Article PubMed PubMed Central CAS Google Scholar
Chiu K, Zhou Y, Yeung SC, et al. Up-regulation of crystallins is involved in the neuroprotective effect of wolfberry on survival of retinal ganglion cells in rat ocular hypertension model. J Cell Biochem. 2010;110(2):311–20.
Article PubMed CAS Google Scholar
He Z, Zhao D, van Koeverden AK, et al. A model of glaucoma induced by circumlimbal suture in rats and mice. J Visualized Experiments. 2018;2018:140.
Buie LKK, Karim MZ, Smith MH, et al. Development of a model of elevated intraocular pressure in rats by gene transfer of bone morphogenetic protein 2. Invest Ophthalmol Vis Sci. 2013;54(8):5441–55.
Article PubMed PubMed Central CAS Google Scholar
Di Marsico L, Sturlese Verduri A, Marracci S, Amato R, Dal Monte M. Rodent Models of Glaucoma: How Mice and Rats Can Help Human Vision Move Out of the Woods and Into the Light. Cells. 2025;14(21):1648.
Comments (0)